Validation of the Spanish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)

Epilepsy and Behavior

Volumn 24, Issue 4, 2012, Pages 493-496

  Di Capua, Daniela ^a   Garcia Garcia, Maria Eugenia ^a   Reig Ferrer, Abilio ^b   Fuentes Ferrer, Manuel ^a   Toledano, Rafael ^c   Gil Nagel, Antonio ^c   Garcia Ptaceck, Sara ^a   Kurtis, Monica ^c   Kanner, Andres M ^d   Garcia Morales, Irene ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c HOSPITAL RUBER INTERNACIONAL   (Spain)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

Major depressive episode; NDDI E; Patients with epilepsy; Psychiatric comorbidity; Screening tool

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ASSESSMENT TOOL; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGICAL DISORDERS DEPRESSION INVENTORY FOR EPILEPSY; OUTPATIENT; PREDICTIVE VALUE; SCREENING; SENSITIVITY AND SPECIFICITY; SPAIN; VALIDATION PROCESS;

ADULT; AREA UNDER CURVE; DEPRESSION; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SPAIN; TRANSLATING;

EID: 84864323404     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.06.005     Document Type: Article

References (29)

1. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48(12):2336-2344.
2. Gilliam F., Hecimovic H., Sheline Y. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav 2003, 4(1004):26-30.
3. Ettinger A., Reed M., Cramer J., for the Epilepsy Impact Project Group Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 2004, 63(6):1008-1014.
4. Gaitatzis A., Trimble M.R., Sander J.W. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004, 110(4):207-220.
5. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62(2):258-261.
6. Canuet L., Ishii R., Iwase M., et al. Factors associated with impaired quality of life in younger and older adults with epilepsy. Epilepsy Res 2009, 83(1):58-65.
7. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45(5):544-550.
8. Kwon O.-Y., Park S.-P. What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?. Epilepsy Behav 2011, 20(3):528-532.
9. Cramer J.A., Blum D., Fanning K., Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004, 5(3):337-342.
10. Lee W.C., Arcona S., Thomas S.K., Wang Q., Hoffmann M.S., Pashos C.L. Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorder. Epilepsy Behav 2005, 7(1):123-126.
11. Christensen J., Vestergaard M., Mortensen P.B., Sidenius P., Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007, 6(8):693-698.
12. Hitiris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75(2-3):192-196.
13. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006, 5(5):399-405.
14. de Oliveira G.N.M., Kummer A., Salgado J.V., et al. Brazilian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav 2010, 19(3):328-331.
15. Friedman D.E., Kung D.H., Laowattana S., Kass J.S., Hrachovy R.A., Levin H.S. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure 2009, 18(6):429-433.
16. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
17. Bobes J. A Spanish validation study of the Mini International Neuropsychiatric Interview. Eur Psychiatry 1998, 13(1004):198s-199s.
18. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 34-57].
19. Brislin R.W. Back-translation for cross-cultural research. J Cross Cult Psychol 1970, 1(3):185-216.
20. Cole A.J. New screening tool for identifying major depression in patients with epilepsy. Nat Clin Pract Neurol 2006, 2(12):656-657.
21. Kondziella D., Asztely F. Don't be afraid to treat depression in patients with epilepsy!. Acta Neurol Scand 2009, 119(2):75-80.
22. Thomé-Souza M.S., Kuczynski E., Valente K.D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 2007, 10(3):417-425.
23. Hovorka J., Herman E., Nemcová I.I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 2000, 1(6):444-447.
24. Kühn K.U., Quednow B.B., Thiel M., Falkai P., Maier W., Elger C.E. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003, 4(6):674-679.
25. Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 2000, 1(2):100-105.
26. Favale E., Audenino D., Cocito L., Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003, 12(5):316-318.
27. Mula M., Schmitz B. Depression in epilepsy: mechanisms and therapeutic approach. Ther Adv Neurol Disord 2009, 2(5):337-344.
28. Prueter C., Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci 2005, 17(1):20-28.
29. Nemeroff C.B., Entsuah R., Benattia I., Demitrack M., Sloan D.M., Thase M.E. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry 2008, 63(4):424-434.